Akebia Therapeutics Inc. buy StockNews.com
Start price
20.04.24
/
50%
€1.28
Target price
20.04.25
-
Performance (%)
36.64%
End price
21.04.25
€1.75
Summary
This prediction ended on 21.04.25 with a price of €1.75. With a performance of 36.64% the BUY prediction by StockNews_com was a big success. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 4.504% | 4.504% | -23.551% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.80
31.12.24
31.12.24
-
31.12.25
31.12.25
-26.82%
03.01.26
03.01.26
